HIRU, Hiru Corporation, HIRU.PK
HIRU and its main subsidiary Jiangxi Shuangshi Animal Health Products Co. (Shuangshi AHP Co.) focus on the development, manufacturing and marketing of a broad range of veterinary products for the Chinese Agricultural market. The company has established a strong position in the Chinese animal husbandry market and plans to expand and deliver more new products and solutions to this market in the future.
HIRU's subsidiary Shuangshi AHP reported that its sales department recently held a large-scale product promotion fair.
Shuangshi AHP Co.'s sales department held a large-scale product promotion fair to present its customers the opportunity to review the full roster of Shuangshi AHP Co.'s animal health products and offer the sales force the opportunity to connect and create closer ties with their customers.
The fair attracted many people, with many customers placing orders right on the spot. The total order amount generated about 300,000 Yuan (approximately $45,000 USD) by the end of the fair.
Furthermore, HIRU is considering a merger with a Canada-based health products company. This company (which has distributors and franchise outlets opening across the country) operates a full-service natural health clinic and distributes its signature brand of health products.
The company's various products promote brain health, pain management and hormone balance, and help combat high blood pressure and high cholesterol. These products come highly regarded by the Chinese market, and have already received positive online testimonials from consumers who say using the products improved their health.
More about HIRU at www.hirucorporation.com
Dreyfus Municipal Income Inc. (AMEX:DMF) reported on November 22, 2010, it is declared from net investment income a monthly cash dividend of $0.0525 per share of common stock, payable on December 31, 2010, to shareholders of record at the close of business on December 10, 2010. The ex-dividend date is December 8, 2010. This dividend increase of $0.0050 per share of common stock from the previous dividend of $0.0475 per share of common stock declared in October is due primarily to lower borrowing costs.
Dreyfus Municipal Income, Inc. operates as a nondiversified, closed-end management investment company in the United States. It primarily invests in municipal bonds. The fund?s portfolio primarily includes investments in companies operating in sewer, housing, healthcare, energy, general obligations, and utility sectors. The Dreyfus Corporation serves as the investment adviser of the fund. Dreyfus Municipal Income was established in 1988 and is based in New York City.
EEGI, Eline Entertainment Group Inc., EEGI.PK
EEGI is a publicly traded company with two subsidiaries: Vu365 and Let the Good Times Roll (LTGTR).
Vu365 is a popular China-based video game designer. Founded in 2005, the group designs online and casual video games including strategic web games, cyber games and 3D large scale competitive games and has several products in development.
Vu365 offers revenues in the $2 million USD range, with profits of $500,000 USD.
Let the Good Times Roll (LTGTR ) is a Delaware-based luxury transportation company with a basis of operations in Florida. It offers transportation to and from events in a one of a kind party atmosphere that makes any celebration memorable. LTGTR strives to provide the utmost in safety, courtesy and service while escorting guests in their fully equipped fleets.
Recently, LTGTR reported a joint venture with the Hard Rock Hotel and Casino.
This new incentivized agreement with provides LTGTR riders with $25-$35 in gaming chips and a $5 food voucher when booked for the Hard Rock Casino. LTGTR, will experiment and plans to start running shuttles to the Hard Rock, charging $25-30 for round trip services. The deal is conditionally approved and subject to pending insurance verification. The company sees this as a simple administrative task, and to be resolved shortly.
Preliminary research shows strong support with the company running 14 casino runs a week, with each shuttle generating an average of $750 in revenue with 60-70% in gross profit.
More about EEGI at www.elineentertainment.com
Targa Resources Corp., formerly known as Targa Resources Investments Inc., the owner of the general partner of Targa Resources Partners LP (NYSE:NGLS), reported that it will commence an initial public offering of 13,750,000 shares of its common stock pursuant to a registration statement on Form S-1 previously filed with the Securities and Exchange Commission.
The underwriters will be granted a 30-day option to purchase up to an additional 2,062,500 shares of common stock. Targa Resources Corp. will not receive any proceeds from the offering as all of the shares will be sold by existing stockholders of the company.
YM BioSciences Inc. (AMEX:YMI) reported on November 18, 2010 that the Phase I/II clinical trial for its orally available JAK1/JAK2 inhibitor, CYT387, in patients with myelofibrosis has been expanded to five sites. Of the additional sites, the Stanford Cancer Center (Stanford, California) under Principal Investigator Jason Gotlib, MD has already commenced enrolling patients. YM also announced that the trial protocol has been extended to allow patients who have derived a clinical benefit to continue to receive treatment beyond the nine cycles of the core protocol. Subjects enrolled in the extension protocol will be evaluated every three months for up to 24 cycles of CYT387 treatment. COO of YM BioSciences. "We anticipate this trial will be fully enrolled in the first calendar quarter of 2011 and that interim data from the fully-enrolled Phase II portion of the study will be available in mid-2011. We also look forward to the presentation of detailed results from the first 60 patients treated in the Phase I and early Phase II portion of this trial at the American Society of Hematology conference in early December 2010."
YM Biosciences Inc., a biopharmaceutical company, engages in the licensing and commercialization of drug products and technologies primarily for the treatment of cancer or cancer-related conditions worldwide. Its approved product Nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor, is used for the treatment nasopharyngeal carcinomas, head and neck cancer, refractory children glioma, adult glioma, and stage III/IV glioma.
Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for Eline Entertainment Group, Inc. (OTCPK:EEGI). Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for Hiru Corporation (OTCPK:HIRU).